Navigation Links
ValGenesis Suite 2.5 Certified by SAP as Powered by SAP NetWeaver®
Date:2/17/2012

FREMONT, Calif., Feb. 17, 2012 /PRNewswire/ -- ValGenesis, Inc., a world-class provider of Validation Lifecycle Management Systems (VLMS), announced today that its innovative ValGenesis Suite 2.5 has achieved SAP certification as powered by the SAP NetWeaver® technology platform. Attaining this certified integration status deepens ValGenesis' active and on-going commitment to SAP® solutions.

The SAP Integration and Certification Center (SAP ICC) has certified that ValGenesis Suite 2.5 integrates with the SAP NetWeaver Process Integration (SAP NetWeaver PI) component of the SAP NetWeaver platform to exchange critical data with instances of SAP Business Suite software. This was certified via the NW-XI-CNT 3.0 interface scenario.

Regulated manufacturing companies are compelled to plan, implement and document validation activities for instruments, equipment, computer systems, processes and the methods used for product manufacturing, as a way of meeting regulatory requirements. Predominantly, these processes are managed manually in a paper-based process. The ValGenesis Suite manages all these processes 100 percent electronically, in addition to enhancing compliance, improving consistency, significantly reducing validation cycle time and removing any inefficiencies that plague paper-based validation processes.

Regulated manufacturing companies also use SAP solutions for manufacturing processes, plant maintenance and asset management, and as such must have real-time validation status of assets, including instruments, equipment, and computer systems, both during manufacturing and maintenance stages. Currently, these systems are validated and managed largely through a manual, paper-based process, leading to tremendous amounts of information in different formats and storage silos. The ValGenesis ERP Connector 2.5 integrated with SAP solutions enables customers to manage their manufacturing process with real-time validation status.

"ValGenesis is an ideal complement to the SAP NetWeaver platform," states Siva Samy, Chief Product Strategist at ValGenesis, Inc. "The ValGenesis Suite enables organizations to further leverage their existing investment in SAP software. Managing the qualification and validation of all assets in ValGenesis, and ValGenesis ERP Connector takes care of updating the real-time validation status of assets in SAP solutions. The ValGenesis Suite, integrated with the SAP NetWeaver platform, allows corporate leaders to monitor the validation status of any instrument or piece of equipment, in real time, for any site. As a result of this integration, ValGenesis looks forward to providing continued support with SAP solutions and anticipates providing a robust closed-loop validation framework that meets the needs of regulated manufacturing customers."

About ValGenesis

ValGenesis, Inc. is the provider of an innovative software platform designed to provide the foundation for compliance-based validation activities in Life Sciences companies. ValGenesis provides the first Enterprise application to automate the corporate validation lifecycle and to track Validation Inventory in real time. Through an industry peer review committee, the Parenteral Drug Association (PDA) recognized the ValGenesis solution with its very prestigious New Innovative Technology award for 2005. The ValGenesis Suite is designed to be fully compliant with U.S. FDA 21 CFR Part 11 requirements. For more information, visit the ValGenesis website at http://www.valgenesis.com.

ValGenesis is a trademark of ValGenesis, Inc. SAP, SAP NetWeaver and all SAP logos are trademarks or registered trademarks of SAP AG in Germany and in several other countries. All other product and service names mentioned herein are the trademarks of their respective owners.

Contact Information:
Mike Beaudro, Marketing Manager
ValGenesis, Inc.
Phone: 510-445-0505
Email: Mike.Beaudro@ValGenesis.com
Web: http://www.valgenesis.com

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>
SOURCE ValGenesis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Announcing ValGenesis On-Demand SaaS Solution
2. ValGenesis, Inc., the Leading Provider of Validation Lifecycle Management Solutions to Regulated Life Science Companies, Today Announced Support for EMC Documentum v.6.5
3. ValGenesis, Inc. Announces Integration of ValGenesis Solution with Microsoft SharePoint Server
4. EdgeBio Selects Calipers Sample Preparation Suite for High Throughput and Benchtop Sequencing Workflows
5. Account Management Training Suite Delivers Two Key Performance Dimensions
6. Magellan Biosciences and Miacom Diagnostics Team Up to Enable Faster, Easier Identification of Pathogens as Part of Magellans End-to-End Suite of Microbiology Products Designed to Streamline Lab Workflow and Enable Better Treatment Decisions
7. Sigma® Life Science Launches Suite of Knockout Rats to Model Parkinsons Disease
8. West Coast Clinical Trials Selects OmniComm Systems TrialOne® Suite to Automate Phase I Clinic Operations
9. Intrasphere Technologies Achieves Oracle PartnerNetwork Specialization for Oracle Argus Safety Suite
10. Hospital Marketplace E-Course Suite Adds Insight on Quality and Information Systems
11. Saunders Solutions for Vets Professional Skills Online-course Suite Wins a Prestigious 2010 Brandon Hall Excellence in Learning Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... 23, 2017  GlobeImmune, Inc. today announced it has ... of 12,835,490 shares of its common stock to NantCell, ... connection with the sale of its common stock, NantCell ... issue to GlobeImmune 200,000 shares, an estimated $2.0 million ... "We are pleased to enter into this strategic agreement ...
(Date:3/23/2017)... March 23, 2017 NetworkNewsWire Editorial Coverage  ... Cancer ... significant strain on health care systems, in terms of costs ... so too does the development of innovative and efficient therapies ... Among the many types of cancer treatments, a growing number ...
(Date:3/23/2017)... ... March 23, 2017 , ... Advanced Polymer Monitoring Technologies ... Dr. Sigmund “Sig” Floyd as Vice President ? Global Business Development. Dr. Floyd ... , “Dr. Floyd’s career has spanned 30 years in the chemicals and equipment ...
(Date:3/22/2017)... 2017  UBM and the Massachusetts Medical Device ... partnership and the third annual Massachusetts Medtech Week. Massachusetts ... st Annual MassMEDIC Conference held in conjunction ... 2017. MassMEDIC will feature a ... and CEO, Scott Whitaker , at its ...
Breaking Biology Technology:
(Date:2/27/2017)... --  Strategic Cyber Ventures , the industry,s first cybersecurity ... million investment in  Polarity , the first commercial human ... based and is led by cybersecurity veterans Tom ... Gula , also a longtime cybersecurity veteran and founder ... A round of funding. This new funding will be ...
(Date:2/21/2017)... Der weltweite Biobanking-Sektor wird bis ... Gespräch mit mehr als 50 Vertretern aus verschiedenen Branchen wurde ... um diese Prognose zu realisieren. ... Zu den Schwierigkeiten ... Mittel für die Biobank, die Implementierung Zeit sparender Technologien, ...
(Date:2/10/2017)... Research and Markets has announced the addition of ... Commercial Aspects" to their offering. ... Biomarkers play an important ... selection of treatment as well for monitoring the results. There ... modern medicine. Biochip/microarray technologies and next generation sequencing are also ...
Breaking Biology News(10 mins):